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Abstract
Background To report the 6-month clinical outcome of
Descemet’s stripping automated endothelial keratoplasty
(DSAEK) for bullous keratopathy (BK) secondary to argon
laser iridotomy (ALI), and compare the results with those of
DSAEK for pseudophakic bullous keratopathy (PBK) or
Fuchs’ endothelial dystrophy (FED).
Methods A total of 103 patients (54 with ALI, 28 with PBK,
21 with FED) undergoing DSAEK were retrospectively
analyzed. Simultaneous cataract surgery was performed in
37 patients with ALI and 13 with FED. Preoperative ocular
conditions, best spectacle-corrected visual acuity (BSCVA),
spherical equivalent refraction (SE), induced astigmatism,
keratometric value, endothelial cell density (ECD), and com-
plications were determined over 6 months postoperatively.
Results Mean axial length in the ALI group (21.8±0.8 mm)
was significantly shorter than that in the FED (P00.02) or
PBK groups (P00.003). Severe corneal stromal edema (n0
6), advanced cataract (n010), posterior synechia (n03),
poor mydriasis (n05), and Zinn zonule weakness (n01)
were found only in the ALI group. A significant improvement
was observed in postoperative BSCVA in all groups. No
significant difference was observed in BSCVA, SE, induced
astigmatism, keratometric value, ECD, or complications
among the three groups.
Conclusions Descemet’s stripping automated endothelial
keratoplasty for BK secondary to ALI showed rapid post-
operative visual improvement, with similar efficacy and
safety to that observed in DSAEK for PBK or FED.
Keywords Descemet’s stripping automated endothelial
keratoplasty . Argon laser iridotomy . Fuchs’ dystrophy .
Pseudophakic bullous keratopathy . Posterior lamellar
keratoplasty
Introduction
The cause of bullous keratopathy (BK), one of the main
reasons for corneal transplantation worldwide, differs by
region. For example, in addition to cataract surgery, Fuchs’
dystrophy is a major cause of BK in western countries [1].
In Japan, on the other hand, argon laser iridotomy (ALI) is
the second most common cause for BK according to a recent
national survey [2, 3]. Bullous keratopathy secondary to
ALI (ALI-BK) can occur long after ALI, and both eyes with
angle-closure glaucoma and those that have undergone pro-
phylactic ALI may be affected. Descemet’s stripping auto-
mated endothelial keratoplasty (DSAEK), a lamellar corneal
surgical procedure, allows selective replacement of the pos-
terior layers of the cornea in the treatment of BK [4, 5]. The
advantages of DSAEK over conventional penetrating kera-
toplasty include the need for only a small incision to be
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made, maintenance of structural integrity of the cornea,
rapid visual recovery, and minimal induction of astigmatism
[6–8]. However, when DSAEK is performed for ALI-BK,
several challenges arise. These eyes characteristically have
shallow anterior chambers which may render anterior cham-
ber surgical maneuvers more difficult and risky. Therefore,
DSAEK for ALI-BK is often technically challenging, even
for well-experienced surgeons [9]. However, hitherto,
reports on the surgical outcome of DSAEK for ALI-BK
have only involved small patient samples [9, 10]. The inci-
dence and management of the intra- and postoperative com-
plications and visual outcomes of DSAEK for ALI-BK
remain largely unknown. The aim of this study was to
investigate the 6-month clinical outcome of DSAEK for
ALI-BK, and to compare with those undergone DSAEK
for other causes of BK (Fig. 1).
Patients and methods
Patients
The medical records of all consecutive patients undergoing
DSAEK for BK resulting from ALI, Fuchs’ endothelial
dystrophy (FED), or pseudophakic bullous keratopathy
(PBK) between April 2007 and December 2010 at Tokyo
Dental College Ichikawa General Hospital were retrospec-
tively reviewed (Table 1). Patients were excluded from the
analysis because of the following reasons; combined causes
suspected such as ALI and FED (three cases), previous
history of penetrating keratoplasty (eight cases), macular
dysfunction due to previous retinal detachment (two cases) or
Axenfeld-Rieger syndrome (one case), and end-stage glauco-
ma without central visual field (one case), or BK due to birth
injury with corneal stromal opacity (two cases). The present
study adhered to the tenets of the Declaration of Helsinki.
Surgical procedures and postoperative treatment
After sub-Tenon or retrobulbar injection of 2% lidocaine, a
5.0-mm temporal or superior corneoscleral incision was made
(details in Table 2). An anterior-chamber maintenance cannula
was inserted for paracentesis. Descemet’s membrane stripping
was performed with a diameter corresponding to the graft size,
using a reverse-bent Sinsky hook (ASICO, Westmont, IL,
USA) and an epithelial trephine marker. In most cases, the
graft size was 8.0 mm, as shown in Table 2. Apart from seven
eyes (13%) in the ALI group and four eyes (14%) in the PBK
group in which nDSAEK were performed [10], the recipient’s
endothelium and Descemet’s membrane were carefully
removed by forceps. Pre-cut donor grafts were trephinated
and the endothelial surface of the lenticle coated with a small
amount of viscoelastic material (Viscoat®, Alcon, Fort Worth,
TX, USA). Donor tissue was gently inserted into the anterior
chamber using a Busin glide (ASICO, Westmont, IL, USA)/
IOL glide and Shimazaki DSAEK forceps (Inami, Tokyo,
Japan). Pull-through technique was used to insert the donor
graft, except in six eyes (three eyes in the ALI group, two eyes
in the PBK group and one eye in the FED group) in which the
folding technique was used. Air was carefully injected into the
anterior chamber to unfold the graft. Fluid from between the
recipient’s stroma and the graft was drained via small incisions
in the midperipheral recipient cornea. Ten minutes after air
injection, most of the air was replaced with balanced salt
solution (BSS plus®, Alcon, Fort Worth, TX, USA). At the
end of the procedure, subconjunctival tobramycin 4 mg
(Tobracin®, J-Dolph, Shiga, Japan) and betamethasone
0.4 mg (Rinderon®, Shionogi, Osaka, Japan) were adminis-
tered. In patients with significant lens opacity, standard pha-
coemulsification and aspiration, and implantation of an
intraocular lens were performed prior to DSAEK using the
phaco-chop technique. Postoperative medication included
0.1% levofloxacin (Cravit®, Santen, Osaka, Japan) and
0.1% betamethasone sodium phosphate (Sanbetazon®,
Santen, Osaka), starting at 5 times a day for 3 months and
then tapering off thereafter.
Examinations
Best spectacle-corrected visual acuity (BSCVA), spherical
equivalent (SE), induced astigmatism [11], keratometric value
(K value), and endothelial cell density (ECD) were measured
pre- and postoperatively at 1, 3 and 6 months. Preoperative
corneal opacity was semi-quantitatively graded using slit-
Fig. 1 Slit-lamp photographs of three patients in ALI group taken
preoperatively (a, b, c). Two cases (a, b) had severe corneal stromal
edema with Descemet membrane fold with hard cataract. One case (c)
had mild corneal stromal edema and rock-hard cataract with Zinn
zonule weakness and poor mydriasis. DSAEK with cataract surgery
had been performed safely on all patients
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lamp biomicroscopy as follows: grade 0: clear and normal;
grade 1: slightly hazy, but iris cleft visible; grade 2: iris cleft
difficult to identify; grade 3: iris cleft impossible to identify.
Cataracts were graded according to the Emery–Little
Table 1 Patient demographics
ALI (N=54) PBK (N=28)  P value FED (N=21) P value 
Age (year) 76±6.0 76±6.0 NS* 67±9.0 NS* 
Female/Male 49/5 21/7 0.096 17/4 0.03
5.1±8.22*810.04.2±1.328.0±8.12)mm(htgnellaixA <0.001* 
Presence of tube in anterior chamber 
(eyes, %) 
0 (0%) 0 (0%) - 0 (0%) - 
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Simultaneous cataract surgery (eyes, %) 37 (68.5%) 0 (0%) - 13 (61.9%) 0.60
Cataract surgery on beforehand (eyes, %) 9 (7.4%) 0 (0%) 0 (0%) -
*Mann–Whitney U test
**χ2 test ☨ Fisher exact test
Table 2 Details of surgical pro-
cedure of DSAEK in each
groups
ALI (n054) PBK (n028) FED (n021)
Descemet’s stripping endothelial keratoplasty (eyes, %) 47 (87%) 24 (86%) 21 (100%)
Non-Descemet’s stripping endothelial keratoplasty (eyes, %) 7 (13%) 4 (14%) 0 (0%)
Graft size (eyes)
7.0 mm 1 0 0
7.5 mm 1 0 0
7.75 mm 1 1 1
8.0 mm 51 26 19
8.25 mm 0 0 1
8.5 mm 0 1 0
Location of corneoscleral incision (eyes, %)
Temporal 51 (94%) 23 (82%) 20 (95%)
Superior 3 (6%) 5 (18%) 1 (5%)
Corneal epithelial removal (eyes, %) 13/54 (24%) 1/28 (3.6%) 4 (19%)
Trypan blue staining (eyes, %) 3/37 (8.1%) 0 (0%) 0 (0%)
Multiple sphincterotomy (eyes, %) 3/37 (8.1%) 0 (0%) 0 (0%)
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classification. Poor preoperative mydriasis was defined as a
pupil diameter of less than 5 mm after instillation of tropica-
mide and phenylephrine 3 times per 10 minutes. Decimal
values of BCSVA were converted to logarithm for statistical
analysis. Endothelial cell density was measured using a
specular microscope (SP-3000P®, Tomey, Nagoya, Japan).
Intra- and postoperative complications were also recorded.
Statistical analysis
The Mann–Whitney U, Wilcoxon, Kruskal–Wallis, χ2 tests
and Fisher’s exact test were used for the statistical analysis. A
P value of less than 0.05 was considered to indicate statistical
significance. All statistical analyses were performed with the
SSRI software (SSRI Co. Ltd., Tokyo, Japan).
Results
Preoperative ocular conditions
Table 1 summarizes the demographic data on the 103
eyes with BK analyzed in this study, which included 54
with ALI-BK (ALI group), 28 with PBK (PBK group),
and 21 with FED (FED group). The proportion of eyes
that had simultaneous cataract surgery is shown in Ta-
ble 1. Mean axial length was significantly smaller in
ALI group than in FED (P00.02) or PBK groups (P0
0.0003, Mann–Whitney U test). As shown in Table 1,
the grade of corneal opacity was similar in each group.
However, severe corneal stromal edema with descemet’s
membrane fold occurred in six eyes (11%) in ALI
group. Moreover, posterior synechia (n03) and poor
mydriasis (n05) occurred more frequently in ALI group.
Mean grade of cataract was significantly higher in ALI
group than in FED group, with grade 5 cataract found
only in ALI group (Table 1). Higher than grade 4
cataract occurred significantly more often in the ALI
group than in the FED group (P00.023; Fisher exact
test). As shown in Table 2, various types of intraoper-
ative manipulation, including corneal epithelium remov-
al, trypan blue-assisted phacoemulsification and multiple
sphincterotomy, were required only in ALI group.
BSCVA, induced astigmatism, SE and K value
All eyes were followed up for a minimum of 6 months
postoperatively. Clarity was maintained in the donor graft
at postoperative month 6 in 50 eyes (92.6%) in ALI group,
26 eyes (92.9%) in PBK group, and 20 eyes (95.2%) in FED
group. Table 3 summarizes BSCVA at preoperative and
postoperative months 1, 3 and 6. With regard to postopera-
tive BSCVA, 53 eyes (98.1%) in ALI group, 26 eyes
(92.9%) in PBK group and 19 eyes (90.4%) in FED group
showed improved BSCVA. Forty-four eyes (81.5%) in ALI
group, 19 eyes (67.9%) in PBK group and 14 eyes (66.7%)
in FED group achieved a BSCVA of 20/40 or better at
6 months. A significant improvement was observed in
BSCVA from 1 month after DSAEK in each group (P<
0.0001 in ALI group, P00.0006 in PBK group, and P0
0.0004 in FED group; Wilcoxon test). In ALI and PBK
groups, BSCVA improved significantly from 1 month to
3 months postoperatively (P<0.0001 in ALI group and P0
0.0065 in PBK group; Wilcoxon test). Table 4 shows the
results of refractive data. No significant difference was
observed in induced astigmatism throughout the postopera-
tive observation period in each group. No significant differ-
ence was observed in SE between the preoperative and
postoperative 1-month values in any group. A significant
difference was observed in SE between postoperative month
1 and 6 in FED group (P00.046, Wilcoxon test). No signif-
icant differences were observed in preoperative and 1-, 3-,
and 6-month postoperative K values in any group.
Endothelial cell loss
Table 5 summarizes ECD of donor preoperatively and ECD
at postoperative month 1, 3 and 6. Preoperative ECD
Table 3 The average of best spectacle-corrected visual acuity (BSCVA)
BSCVA (LogMAR±SD) ALI (range) PBK (range) FED (range) P value
Preoperative 1.27±0.64 (0.16 to 3) 1.41±0.59 (0.52 to 2.7) 0.88±0.49 (0.3 to 2)
1 m 0.60±0.63 (0.16 to 3) 0.78±0.64 (0.3 to 2.7) 0.44±0.46 (0.16 to 2) NS*
3 m 0.43±0.57 (0 to 2.7) 0.65±0.67 (0.1 to 2.7) 0.39±0.44 (0.05 to 2) NS*
6 m 0.34±0.60 (−0.08 to 2.7) 0.50±0.65 (0 to 2.7) 0.21±0.30 (0 to 1) NS*
Eyes showing improved BSCVA (eyes) 53 (98.1%) 26 (92.9%) P00.27☨ 19 (90.4%) P00.19☨
Postoperative BSCVA>20/40 (eyes) 44 (81.5%) 14 (66.7%) P00.18☨☨ 19 (67.9 %) P00.22☨☨
*Kruskal–Wallis test comparing the difference among three groups
☨ Fisher’s test comparing the number of eyes showing improved BSCVA between in ALI group and PBK group or FED group
☨☨ Fisher’s test comparing the number of eyes showing postoperative BSCVA>20/40 between in ALI group and PBK group or FED group
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significantly decreased 1 month after DSAEK (P<0.0001 in
ALI group, P00.043 in PBK group, and P00.012 in FED
group; Wilcoxon test). In addition, postoperative ECD sig-
nificantly decreased from month 3 (1174±361 cells/mm2) to
month 6 (944±386 cells/mm2) in PBK group (P00.017;
Wilcoxon test), although no rejection episode occurred
between 3 and 6 months in this group.
Complications
Complications are summarized in Table 6. No significant
differences were observed in incidence of intra- or postop-
erative complications among the three groups. Three eyes
out of 37 eyes (8.1%) in ALI group showed posterior
capsule rupture intraoperatively. In two of these three eyes,
an intraocular lens was inserted into the capsular bag, while
in the remaining eye the lens was fixed to the sulcus. Twelve
out of 103 eyes (11.5%) (six eyes in ALI group, three eyes
in PBK group and three eyes in FED group) showed dislo-
cation of the donor corneal lenticle at day 1 postoperatively,
with each undergoing successful reattachment with one or a
pair of air bubble tamponades. Pupillary block glaucoma
secondary to anterior chamber air bubble occurred in three
out of 103 eyes (2.9%) (one eye in ALI group and two eyes
in PBK group) on the day of surgery, and was successfully
treated by air removal. One out of 103 eyes (0.97%) (PBK
group) developed acute graft rejection characterized by mild
inflammation in the anterior chamber and keratic precipi-
tates on the donor endothelium. In this case, graft rejection
was treated with intensive topical and intravenous cortico-
steroid therapy. No case underwent re-keratoplasty within
6 months. Postoperative ocular hypertension developed in
six eyes (three eyes in ALI group, one eye in PBK group
and two eyes in FED group) and was treated with anti-
glaucoma eye drops. Cystoid macular edema was found in
one eye in ALI group, and was treated with intensive instil-
lation of 0.1% diclofenac sodium (Diclod®, Wakamoto
Pharmaceuticals, Tokyo, Japan).
Discussion
We evaluated the 6-month clinical outcome of Descemet’s
stripping automated endothelial keratoplasty (DSAEK) for
BK secondary to ALI and compare the results with those of
DSAEK for pseudophakic bullous keratopathy (PBK) or
Fuchs’ endothelial dystrophy (FED). We demonstrated that
DSAEK for BK secondary to ALI showed rapid postopera-
tive visual improvement, with similar efficacy and safety to
that observed in DSAEK for PBK or FED.
Bullous keratopathy secondary to ALI is becoming in-
creasingly common in Asian countries, especially in Japan
[2, 3, 12–15], where a national survey revealed that ALI-BK
accounted for approximately one-fourth of BK cases
Table 4 Graft survival rate and
refractive data
Data were presented as mean±
SD. *Kruskal–Wallis test com-
pared the difference among three
groups
ALI PBK FED P value
Graft survival rate at postoperative 6 m (eyes, %) 50 (92.6%) 26 (92.9%) 20 (95.2%)
Induced astigmatism (D)
1 m 1.4±1.2 2.5±2.1 2.3±1.4 0.007*
3 m 1.5±1.1 2.3±1.1 2.0±1.6 0.036*
6 m 1.5±1.0 1.8±0.7 1.7±1.3 NS*
Spherical equivalence (D)
Preoperative 0.69±2.6 −0.74±1.86 −0.25±1.5 NS*
1 m 0.31±1.6 −0.48±2.2 −0.39±2.2 NS*
3 m 0.17±1.2 −0.94±2.0 1.6±5.26 NS*
6 m −0.15±0.78 −0.94±2.0 −2.7±4.3 NS*
Keratometric value
Preoperative 44.5±2.4 43.8±2.0 44.5±2.3 NS*
1 m 43.3±2.4 43.3±2.2 44.0±2.2 NS*
3 m 44.0±2.2 43.6±1.9 43.5±2.6 NS*
6 m 44.0±2.1 43.7±2.1 43.8±1.4 NS*
Table 5 Endothelial cell density (ECD)
ECD(/mm2±SD) ALI PBK FED P value
Donor preoperatively 2339±284 2600±341 2701±332 NS*
1 m 1360±467 1023±260 1158±487 NS*
3 m 1217±485 1174±361 1388±612 NS*
6 m 1124±427 944±386 1230±560 NS*
*Kruskal–Wallis test comparing endothelial cell density among three
groups
Graefes Arch Clin Exp Ophthalmol (2012) 250:1043–1050 1047
undergoing keratoplasty. Most cases of ALI-BK develop
long after laser iridotomy, in which an argon laser is used
[2]. However, the underlying mechanism of ALI-BK
remains unclear. Several hypotheses have been postulated,
including increased temperature in the local aqueous humor
[16], high energy delivered during ALI breakdown of the
blood–aqueous barrier, and change in aqueous humor fluid
dynamics [17, 18].
This study demonstrated that surgery for ALI-BK is
technically challenging, mainly due to the small size of the
eyeball shallow anterior chamber and challenging simulta-
neous cataract surgery in ALI group. In the present study,
the mean axial length of eyes receiving DSAEK for ALI-BK
was less than 22 mm. In addition, advanced cataract is often
associated with this disorder, and physicians are reluctant to
perform surgery due to decreased endothelial density. More-
over, a shortage of donor grafts in Japan often gives rise to
delayed keratoplasty, which makes the procedure even more
challenging. There were also associated problems such as
poor mydriasis and weak Zinn zonule in some cases. To
overcome difficulties in surgery, various supporting surgical
procedures are used, and simultaneous cataract surgery.
Epithelial removal technique was performed in case of in-
visible anterior chamber by strong corneal epithelial edema.
In addition, trypan blue staining was performed to stain
anterior capsule for continuous curvilinear capsulorhexis
(CCC) in the case of severe cataract. In this study, all trypan
blue staining was combined with epithelial removal proce-
dure. The postoperative outcome in eyes with ALI-BK was
comparable to other groups, suggesting that combined
DSAEK and cataract surgery can be performed without
severe complications with the above-mentioned surgical
technique in most cases.
In this study, the average BSCVA 6 month after DSAEK
for ALI-BK was 20/29 with low induced astigmatism.
Seven eyes (12.9%) achieved postoperative BSCVA of 20/
20 or better. Clarity was maintained in the donor graft at
postoperative month 6 in 50 eyes (92.6%). No case under-
went re-keratoplasty within 6 months. These results are
comparable with those of Gorovoy [5], Koenig [6], and
Kobayashi [9] (Table 7). Endothelial cell loss was 52% at
postoperative 6 months, similar to 6-month data reported
previously [6]. Postoperative endothelial loss after DSAEK
for ALI-BK was not significantly different from that in the
other two groups. We were concerned about the possibility
that the ALI group may experience a faster decrease in ECD
than the other groups after DSAEK, because of the patho-
genesis mechanism of ALI. However, the results of this
study showed that the 6-month clinical outcomes of ECD
in DSAEK for ALI-BK were comparable with those of
DSAEK for BK caused by FED or PBK [20, 21]. One of
the explanations may be that simultaneous cataract surgery
eliminates the cause of endothelial cell damage by deepen-
ing the anterior chamber.
Our previous report on PK for ALI-BK showed a similar
result in BSCVA to that of the present study (78.6% of
patients achieved 20/40 or better); however, incidence of
rejection (8.2%) and postoperative glaucoma (18.4%) was
relatively high [22]. The refractive outcome at postoperative
6 months of our previous study indicated that PK for ALI-
BK resulted in similar SE (the average was 0.19±4.6 D) to
the present study, and higher induced astigmatism (the
average; 3.3±2.4 D) (unpublished data). Although there
was no report that showed postoperative refraction data of
PK for ALI-BK in detail, PK usually results in unstable
refraction as long as sutures are present, and even after their
removal [23–26]. Bahar et al. reported the comparison of
12-month surgical outcomes of DSAEK and PK [8]. Stabil-
ity of the refraction is a major advantage of all endothelial
keratoplasty techniques as compared with PK. In current
study, the postoperative refraction after DSAEK for ALI-
BK was stable during follow-up terms.
In summary, this study of 6-month outcomes of
DSAEK for BK secondary to ALI showed rapid postopera-
tive visual improvement, with similar efficacy and safety to
that observed in DSAEK for PBK or FED. Although many
of the eyes in ALI group presented technical challenges
during surgery, those challenges could be successfully man-
aged by modification of the procedures and implements
used.
Table 6 Complications
ALI PBK P value* FED P value* Total
Intraoperative Posterior capsule rupture (eyes, %) 3 (8.1%) 0 (0%) 0.54 0 (0%) 0.56 3 (2.9%)
Postoperative; early Dislocation (eyes, %) 6 (11%) 3 (11%) 1 3 (14%) 0.70 12 (12%)
Pupillary block (eyes, %) 1 (1.9%) 2 (7.1%) 0.27 0 (0%) 1 3 (2.9%)
Postoperative; chronic Rejection (eyes, %) 0 (0%) 1 (3.6%) 1 0 (0%) 1 1 (0.97%)
Ocular hypertension (eyes, %) 3 (5.5%) 1 (3.6%) 1 2 (9.5%) 0.61 6 (5.8%)
Cystoid macular edema (eyes, %) 1 (1.9%) 0 (0%) 1 0 (0%) 1 1 (0.97%)
*Fisher exact test compared with ALI group
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